| Advagraf 0.5 mg prolonged-release hard capsules EU/1/07/387/001-002 |
Tacrolimus |
Astellas Pharma Europe BV |
— |
| Advagraf 0.5 mg prolonged-release hard capsules EU/1/07/387/1-2 |
Tacrolimus |
Astellas Pharma Europe BV |
— |
| Advagraf 1 mg prolonged-release hard capsules EU/1/07/387/003-006 |
Tacrolimus |
Astellas Pharma Europe BV |
— |
| Advagraf 1 mg prolonged-release hard capsules EU/1/07/387/3-6 |
Tacrolimus |
Astellas Pharma Europe BV |
— |
| Advagraf 3 mg prolonged-release hard capsules EU/1/07/387/011-013 |
Tacrolimus |
Astellas Pharma Europe BV |
— |
| Advagraf 3 mg prolonged-release hard capsules EU/1/07/387/11-13 |
Tacrolimus |
Astellas Pharma Europe BV |
— |
| Advagraf 5 mg prolonged-release hard capsules EU/1/07/387/007-008 |
Tacrolimus |
Astellas Pharma Europe BV |
— |
| Advagraf 5 mg prolonged-release hard capsules EU/1/07/387/7-8 |
Tacrolimus |
Astellas Pharma Europe BV |
— |
| Betmiga 25 mg prolonged-release tablets EU/1/12/809/001-007 |
Mirabegron (ym178) |
Astellas Pharma Europe BV |
— |
| Betmiga 50 mg prolonged-release tablets EU/1/12/809/008-014 |
Mirabegron (ym178) |
Astellas Pharma Europe BV |
— |
| Betmiga 8 mg/ml Granules for prolonged-release oral suspension EU/1/12/809/019-020 |
Mirabegron |
Astellas Pharma Europe B.V. |
— |
| Evrenzo 100 mg Film-coated tablet EU/1/21/1574/004 |
Roxadustat |
Astellas Pharma Europe B.V. |
— |
| Evrenzo 150 mg Film-coated tablet EU/1/21/1574/005 |
Roxadustat |
Astellas Pharma Europe B.V. |
— |
| Evrenzo 20 mg Film-coated tablet EU/1/21/1574/001 |
Roxadustat |
Astellas Pharma Europe B.V. |
— |
| Evrenzo 50 mg Film-coated tablet EU/1/21/1574/002 |
Roxadustat |
Astellas Pharma Europe B.V. |
— |
| Evrenzo 70 mg Film-coated tablet EU/1/21/1574/003 |
Roxadustat |
Astellas Pharma Europe B.V. |
— |
| Modigraf 0.2 mg granules for oral suspension EU/1/09/523/001 |
Tacrolimus |
Astellas Pharma Europe BV |
— |
| Modigraf 1 mg granules for oral suspension EU/1/09/523/002 |
Tacrolimus |
Astellas Pharma Europe BV |
— |
| Omnexel®, 400 micrograms prolonged release tablets, film-coated PA1241/006/001 |
Tamsulosin hydrochloride |
Astellas Pharma Co. Limited |
Marketed |
| Padcev 20 mg Powder for concentrate for solution for infusion EU/1/21/1615/001 |
Enfortumab Vedotin |
Astellas Pharma Europe B.V. |
— |
| Padcev 30 mg Powder for concentrate for solution for infusion EU/1/21/1615/002 |
Enfortumab Vedotin |
Astellas Pharma Europe B.V. |
— |
| Prograf 0.5 mg hard capsules PA1241/014/001 |
Tacrolimus |
Astellas Pharma Co. Limited |
Marketed |
| Prograf 1 mg hard capsules PA1241/014/002 |
Tacrolimus |
Astellas Pharma Co. Limited |
Marketed |
| Prograf 5 mg hard capsules PA1241/014/003 |
Tacrolimus |
Astellas Pharma Co. Limited |
Marketed |
| Prograf 5 mg/ml concentrate for solution for infusion PA1241/014/004 |
Tacrolimus |
Astellas Pharma Co. Limited |
Marketed |
| Protopic 0.1% Ointment EU/1/02/202/003 |
Tacrolimus |
Astellas Pharma GmbH |
— |
| Veoza 45 mg film-coated tablets EU/1/23/1771/001-003 |
Fezolinetant |
Astellas Pharma Europe B.V. |
— |
| Vesitirim 1 mg/ml oral suspension PA1241/009/003 |
Solifenacin succinate |
Astellas Pharma Co. Limited |
Marketed |
| Vesitirim 10 mg film-coated tablets PA1241/009/002 |
Solifenacin succinate |
Astellas Pharma Co. Limited |
Marketed |
| Vesitirim 5 mg film-coated tablets PA1241/009/001 |
Solifenacin succinate |
Astellas Pharma Co. Limited |
Marketed |
| Vesomni 6 mg/0.4 mg modified-release tablets PA1241/016/001 |
Solifenacin succinate, Tamsulosin hydrochloride |
Astellas Pharma Co. Limited |
Marketed |
| Vyloy 100 mg powder for concentrate for solution for infusion. EU/1/24/1856/001-002 |
Zolbetuximab |
Astellas Pharma Europe B.V. |
— |
| Xospata 40 mg film-coated tablets EU/1/19/1399/001 |
Gilteritinib fumarate |
Astellas Pharma Europe B.V. |
— |
| Xtandi 40 mg film-coated tablets EU/1/13/846/002 |
Enzalutamide |
Astellas Pharma Europe B.V. |
— |
| Xtandi 40 mg soft capsules EU/1/13/846/001 |
Enzalutamide |
Astellas Pharma Europe BV |
— |
| Xtandi 80 mg film-coated tablets EU/1/13/846/003 |
Enzalutamide |
Astellas Pharma Europe B.V. |
— |